Human immunodeficiency virus type-1 Tat protein induces secretory leukocyte protease inhibitor expression in African green monkey but not human cells
African monkeys are resistant to HIV-1 infection due to intrinsic restriction mechanisms found in their cells. However, although they can be infected by monkey-adapted modified HIV-1 particles that are designed to overcome known restriction factors, virus numbers drop to undetectable levels in immunocompetent animals. These results indicate the possibility of the presence of yet unidentified factor(s) that restrict HIV-1 in old-world monkey (OWM) cells after integration of the viral genome into the host cell chromosome. In the light of these findings, we hypothesized that OWMs might have evolved resistance mechanism(s) against HIV-1 by switching specific gene(s) on in response to the synthesis of viral proteins in infected cells. In an attempt to mimic post-infection status, we expressed HIV-1 Tat gene in African green monkey cells and compared the whole proteome with normal cells and identified secretory leukocyte protease inhibitor (SLPI), a protein with known extracellular anti-HIV-1 activity, as an over-expressed protein in the presence of HIV-1 Tat protein by 2D-PAGE and mass spectrometry analysis. We also showed that overexpression of SLPI in the presence of HIV-1 Tat was specific to monkey cells. Our results also suggest that SLPI had a previously undiscovered intracellular anti-HIV activity in addition to its extracellular activity.
KeywordsAfrican green monkey HIV-1 tat Secretory leukocyte protease inhibitor Anti-HIV-1 activity
The authors would like to thank to the National Biological Mass Spectrometry and Proteomics Facility, and Biotechnology and Bioengineering Research and Application Centers of Izmir Institute of Technology for their help and technical support.
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by AA, SÖ and BŞ. The first draft of the manuscript was written by AA and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
The research was funded by The Scientific and Technological Research Council of Turkey (TUBITAK), Grant No.: 115S213.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Informed consent was obtained from all individual participants included in the study.
Research involving human and animal participants
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.McCarthy KR, Kirmaier A, Autissier P, Johnson WE (2015) Evolutionary and functional analysis of old world primate TRIM5 reveals the ancient emergence of primate lentiviruses and convergent evolution targeting a conserved capsid interface. PLoS Pathog. https://doi.org/10.1371/journal.ppat.1005085 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Hatziioannou T, Del Prete GQ, Keele BF, Estes JD, McNatt MW, Bitzegeio J, Raymond A, Rodriguez A, Schmidt F, Mac Trubey C, Smedley J, Piatak M, KewalRamani VN, Lifson JD, Bieniasz PD (2014) HIV-1-induced AIDS in monkeys. Science 344(6190):1401–1405. https://doi.org/10.1126/science.1250761 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.de la Fuente C, Santiago F, Deng LW, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu KL, Lee CG, Pumfery A, Kashanchi F (2002) Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem. https://doi.org/10.1186/1472-2091-3-14 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Py B, Basmaciogullari S, Bouchet J, Zarka M, Moura IC, Benhamou M, Monteiro RC, Hocini H, Madrid R, Benichou S (2009) The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS ONE. https://doi.org/10.1371/journal.pone.0005006 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J, Cornelissen ILMHA, Nottet HSLM, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100(5):587–597. https://doi.org/10.1016/S0092-8674(00)80694-7 CrossRefPubMedGoogle Scholar
- 25.Igarashi T, Iyengar R, Byrum RA, Buckler-White A, Dewar RL, Buckler CE, Lane HC, Kamada K, Adachi A, Martin MA (2007) Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J Virol 81(20):11549–11552. https://doi.org/10.1128/Jvi.00960-07 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Saito A, Nomaguchi M, Iijima S, Kuroishi A, Yoshida T, Lee YJ, Hayakawa T, Kono K, Nakayama EE, Shioda T, Yasutomi Y, Adachi A, Matano T, Akari H (2011) Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect 13(1):58–64. https://doi.org/10.1016/j.micinf.2010.10.001 CrossRefPubMedGoogle Scholar
- 30.Jana NK, Gray LR, Shugars DC (2005) Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J Virol 79(10):6432–6440. https://doi.org/10.1128/JVI.79.10.6432-6440.2005 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM (2004) Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol 172(7):4535–4544. https://doi.org/10.4049/jimmunol.172.7.4535 CrossRefPubMedGoogle Scholar
- 34.Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyotl N, Zani ML (2008) Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90(2):284–295. https://doi.org/10.1016/j.biochi.2007.09.007 CrossRefPubMedGoogle Scholar
- 35.Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RMM (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169(6):3400–3406. https://doi.org/10.4049/jimmunol.169.6.3400 CrossRefPubMedGoogle Scholar
- 36.Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, Lange JMA, Hamann D, Prins M, Miedema F (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17(13):1881–1888. https://doi.org/10.1097/01.aids.0000076311.76477.6e CrossRefPubMedGoogle Scholar
- 37.Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narvaez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104(4):942–947. https://doi.org/10.1182/blood-2003-09-3333 CrossRefPubMedGoogle Scholar
- 39.Kornfeld C, Ploquin MJY, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, Desoutter JF, Butor C, Le Grand R, Roques P, Simon F, Barre-Sinoussi F, Diop OM, Muller-Trutwin MC (2005) Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Investig 115(4):1082–1091. https://doi.org/10.1172/Jci200523006 CrossRefPubMedGoogle Scholar
- 40.Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H (2000) Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol 121(1):77–85. https://doi.org/10.1046/j.1365-2249.2000.01269.x CrossRefPubMedPubMedCentralGoogle Scholar